178 related articles for article (PubMed ID: 9675606)
41. Peritoneal cytokines and adhesion formation in endometriosis: an inverse association with vascular endothelial growth factor concentration.
Barcz E; Milewski Ł; Dziunycz P; Kamiński P; Płoski R; Malejczyk J
Fertil Steril; 2012 Jun; 97(6):1380-6.e1. PubMed ID: 22542989
[TBL] [Abstract][Full Text] [Related]
42. Elevated interleukin-6 levels in peritoneal fluid of patients with pelvic pathology.
Buyalos RP; Funari VA; Azziz R; Watson JM; Martinez-Maza O
Fertil Steril; 1992 Aug; 58(2):302-6. PubMed ID: 1633894
[TBL] [Abstract][Full Text] [Related]
43. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
[TBL] [Abstract][Full Text] [Related]
44. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid.
Kinnby B; Matsson L; Astedt B
J Periodontal Res; 1996 May; 31(4):271-7. PubMed ID: 8814598
[TBL] [Abstract][Full Text] [Related]
45. [Peritoneal mesothelium--the role in fibrin transformations].
Winckiewicz M; Staniszewski R; Połubińska A; Breborowicz A
Przegl Lek; 2006; 63(9):778-81. PubMed ID: 17479869
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and mechanism of tanshinone IIA liquid nanoparticles in preventing experimental postoperative peritoneal adhesions in vivo and in vitro.
Qin F; Ma Y; Li X; Wang X; Wei Y; Hou C; Lin S; Hou L; Wang C
Int J Nanomedicine; 2015; 10():3699-716. PubMed ID: 26056449
[TBL] [Abstract][Full Text] [Related]
47. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
Nkere UU; Whawell SA; Thompson EM; Thompson JN; Taylor KM
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):339-45. PubMed ID: 8341074
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.
Xiao Y; Bunn CL; Bartold PM
J Periodontal Res; 1998 Jan; 33(1):17-26. PubMed ID: 9524317
[TBL] [Abstract][Full Text] [Related]
49. [The evaluation of IL-12 levels in peritoneal fluid and serum of women with endometriosis].
Szczepańska M; Mikołajczyk M; Raczyńska P; Skrzypczak J
Ginekol Pol; 2001 May; 72(5):408-17. PubMed ID: 11526785
[TBL] [Abstract][Full Text] [Related]
50. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.
Estellés A; Gilabert J; Andrés C; España F; Aznar J
Thromb Haemost; 1990 Oct; 64(2):281-5. PubMed ID: 2125378
[TBL] [Abstract][Full Text] [Related]
51. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
52. Regulation of expression of tissue plasminogen activator and plasminogen activator inhibitor-1 by dichloroacetic acid in human fibroblasts from normal peritoneum and adhesions.
Diamond MP; El-Hammady E; Wang R; Kruger M; Saed G
Am J Obstet Gynecol; 2004 Apr; 190(4):926-34. PubMed ID: 15118614
[TBL] [Abstract][Full Text] [Related]
53. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
Moniwa N
Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
[TBL] [Abstract][Full Text] [Related]
54. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
de Vries TJ; Kitson JL; Silvers WK; Mintz B
Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
[TBL] [Abstract][Full Text] [Related]
55. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis.
Tarhan OR; Barut I; Sezik M
J Surg Res; 2008 Jan; 144(1):151-7. PubMed ID: 17981298
[TBL] [Abstract][Full Text] [Related]
56. Effect of laparoscopic and conventional colorectal resection on peritoneal fibrinolytic capacity: a prospective randomized clinical trial.
Neudecker J; Junghans T; Ziemer S; Raue W; Schwenk W
Int J Colorectal Dis; 2002 Nov; 17(6):426-9. PubMed ID: 12355220
[TBL] [Abstract][Full Text] [Related]
57. Plasminogen activators in ectopic and uterine endometrium.
Fernández-Shaw S; Marshall JM; Hicks B; Barlow DH; Starkey PM
Fertil Steril; 1995 Jan; 63(1):45-51. PubMed ID: 7805923
[TBL] [Abstract][Full Text] [Related]
58. Plasminogen activators and plasminogen activator inhibitors in endometriosis.
Gilabert-Estelles J; Castello R; Gilabert J; Ramon LA; Espana F; Romeu A; Estelles A
Front Biosci; 2005 May; 10():1162-76. PubMed ID: 15769615
[TBL] [Abstract][Full Text] [Related]
59. Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study.
Hellebrekers BW; Trimbos-Kemper TC; Boesten L; Jansen FW; Kolkman W; Trimbos JB; Press RR; van Poelgeest MI; Emeis SJ; Kooistra T
Fertil Steril; 2009 Apr; 91(4):1204-14. PubMed ID: 18353314
[TBL] [Abstract][Full Text] [Related]
60. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis.
Falkon L; Garí M; Borrell M; Fontcuberta J
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):33-8. PubMed ID: 1623118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
